 |
|
Scientists move closer to developing a new class of asthma and allergy drugs
February 15, 2008A team of Biotechnology and Biological Sciences Research Council (BBSRC) funded scientists has moved a step closer to developing a new class of effective asthma and allergy drugs. With new research published today (15 February) in The Journal of Immunology, the team from Barts and The London School of Medicine and Dentistry has found an important target that holds significant promise for millions of people suffering from allergies, asthma, rheumatoid arthritis and a range of other inflammatory diseases. This work confirms that a key component of the body's own response to allergy-causing agents (allergens) can be targeted to reduce allergic reactions in mice.
At present, the majority of treatments for asthma and allergies focus on reducing symptoms such as an inflamed airway or runny nose and itchy eyes. Because allergies are essentially an over-the-top immune response to allergens (such as dust, peanuts, or insect bites), it is possible to give a treatment that dampens down the immune system. However this is very risky, leaving the person vulnerable to infection, and so is only used in the most extreme cases - for most people treatments that manage the symptoms of allergy are the best option. The BBSRC team led by Professor Bart Vanhaesebroeck has shown that by targeting a molecule called p110delta it is possible to interfere in the allergic reaction before symptoms occur, but without shutting down the immune system.
p110delta is a member of a family of eight proteins called PI3Ks, which control important biological functions. Their activity is implicated in many different diseases including cancer and they are an important target for drugs. However, drugs that act on all PI3K family members tend to be toxic in the body. For this reason Professor Vanhaesebroeck's team uses genetic techniques to find out which PI3K family members are linked to specific diseases. By gaining a better understanding of each PI3K they hope to target drugs more specifically and reduce the potential for side effects.
The p110gamma member of the PI3K family had previously been implicated in allergic reactions and was thought to be more important than p110delta. However, in the current study, Prof Vanhaesebroeck's team has confirmed that p110delta, but not p110gamma, is important for allergic reactions in a mouse model. These results will help to inform and drive decisions in industry to prioritise which PI3K family members should be targeted for further investment and development. The next step to develop p110delta blockers is now ongoing in industry, and is expected to proceed into the preclinical arena in humans in the near future.
Lead author of the study, Dr Khaled Ali said: "p110delta was first identified in 1997 and, and although we had our suspicions, at that time we had no idea how important it would turn out to be. This work shows that we have the potential to take control of the body's reaction to an allergen and prevent symptoms from occurring."
Professor Vanhaesebroeck added: "This work confirms our previous findings and shows once and for all that in an allergic reaction it is p110delta that is the key player among the PI3K molecules. We are very hopeful that a drug for human patients can be developed in the very near future. This approach offers the potential for therapies for asthma and allergies that target the real causes, not just symptoms."
Professor Nigel Brown, BBSRC Director of Science and Technology, said: "Allergies alone cause misery for millions every year and is of significant cost the UK due to lost productivity. This research, basic bioscience funded by BBSRC, together with industry collaboration could mean an entirely new way of dealing with asthma and allergies."
Biotechnology and Biological Sciences Research Council
The p110gamma member of the PI3K family had previously been implicated in allergic reactions and was thought to be more important than p110delta. However, in the current study, Prof Vanhaesebroeck's team has confirmed that p110delta, but not p110gamma, is important for allergic reactions in a mouse model. These results will help to inform and drive decisions in industry to prioritise which PI3K family members should be targeted for further investment and development. The next step to develop p110delta blockers is now ongoing in industry, and is expected to proceed into the preclinical arena in humans in the near future.
Lead author of the study, Dr Khaled Ali said: "p110delta was first identified in 1997 and, and although we had our suspicions, at that time we had no idea how important it would turn out to be. This work shows that we have the potential to take control of the body's reaction to an allergen and prevent symptoms from occurring."
Professor Vanhaesebroeck added: "This work confirms our previous findings and shows once and for all that in an allergic reaction it is p110delta that is the key player among the PI3K molecules. We are very hopeful that a drug for human patients can be developed in the very near future. This approach offers the potential for therapies for asthma and allergies that target the real causes, not just symptoms."
Professor Nigel Brown, BBSRC Director of Science and Technology, said: "Allergies alone cause misery for millions every year and is of significant cost the UK due to lost productivity. This research, basic bioscience funded by BBSRC, together with industry collaboration could mean an entirely new way of dealing with asthma and allergies."
Biotechnology and Biological Sciences Research Council
Asthma Current Events and Asthma News RSSWildfires Cause Ozone Pollution to Violate Health Standards, New Study Shows
Wildfires can boost ozone pollution to levels that violate U.S. health standards, a new study concludes.
Wheezing and asthma in young children
The diagnosis of asthma in a young child may well be more challenging to pediatricians than previously appreciated, according to a review of research and clinical experience literature by Howard Eigen, M.D., of the Indiana University School of Medicine and Riley Hospital for Children appearing in the October 2008 issue of Clinical Pediatrics.
H. Pylori bacteria may help prevent some esophageal cancers
Some bacteria may help protect against the development of a type of esophageal cancer, known as adenocarcinoma, according to a new review of the medical literature. These bacteria, which are called Helicobacter pylori, live in the stomachs of humans.
Children's asthma affected by parental expectations
Asthmatic children whose parents have high expectations for their ability to function normally are less likely to have symptoms than other children dealing with the condition, according to a new study.
Childhood wheezing with rhinovirus can increase asthma odds 10-fold
Infants who experience viral respiratory illnesses with wheezing are known to be at increased risk for developing asthma later during childhood.
UI researchers find potentially toxic substance present in Chicago air
Although the industrial compounds known as polychlorinated biphenols or PCBs have been found in previous air samples collected in the city of Chicago, a University of Iowa researcher says that a new study of Chicago air sampled between November 2006 and November 2007 found PCB11, a byproduct of the manufacture of paint pigments and a potentially toxic substance, present throughout the city.
Steroids Not as Effective in Obese Asthma Patients
Researchers at National Jewish Health have shown that glucocorticoids, the primary controller medication for asthma, are 40 percent less effective in overweight and obese asthma patients than in those of normal weight.
More findings on gene involved in childhood asthma
Asthma researchers have found that a gene variant known to raise the risk of childhood asthma in European children plays a similar role in white American children, but not in African American children.
Common bronchodilator linked to increased deaths
A common bronchodilator drug which has been used for more than a decade by patients with chronic obstructive pulmonary disease (COPD) has been linked to a one-third higher risk of cardiovascular-related deaths.
Cortisol and fatty liver: Researchers find cause of severe metabolic disorders
A healthy body stores fat in the form of so-called triglycerides in specialized fatty tissue as an energy reserve. Under certain conditions the delicate balance of the lipid metabolism gets out of control and fat is accumulated in the liver, leading to the dreaded fatty liver.
More Asthma Current Events and Asthma News Articles
 | Healing the New Childhood Epidemics: Autism, ADHD, Asthma, and Allergies: The Groundbreaking Program for the 4-A Disorders by Kenneth Bock, Cameron Stauth Autism is an epidemic: It has spiked 1,500 percent in the last twenty years. ADHD, asthma and allergies have also skyrocketed over the same time period. One of these conditions now strikes one in every three children in America. But there is hope. Leading medical innovator Kenneth Bock, M.D., has helped change the lives of more than a thousand children, and in this important book, with a... |
 | The Allergy and Asthma Cure: A Complete 8-Step Nutritional Program by Fred, M.D. Pescatore Free yourself of allergies and asthma once and for all with Dr. Pescatore's breakthrough program " Dr. Fred Pescatore's The Allergy and Asthma Cure reveals a unique and revolutionary understanding of the underlying conditions of allergy and asthma-from food triggers to the environment to nutritional deficiencies. His integrative program of both alternative and traditional treatments can... |
 | ABC of A Allergies and Lupus: Eradicate Asthma - Now! by F. Batmanghelidj This book introduces a new discovery that unintentional dehydration causes many painful, degenerative diseases. It explains the direct relationship between water deficiency in the body and allergies, asthma and lupus. You will learn: -How to prevent and cure childhood asthma without medication -How to recognize the signs of an imminent asthma attack -How to identify chronic dehydration... |
 | Reversing Asthma: Breathe Easier with This Revolutionary New Program by Richard N. Firshein D.O. |
 | Asthma-Free Naturally: Everything You Need to Know to Take Control of Your Asthma by Patrick McKeown This revolutionary book teaches readers how to take control of their asthma safely and effectively without any side effects. The approach encompasses the Buteyko Breathing Method as well as guidance on diet, sleep, physical activity, and other lifestyle changes that can provide a natural alternative to Asthma medications. The author was a chronic asthmatic who applied the Buteyko Breathing Method... |
 | Natural Relief for Your Child's Asthma: A Guide to Controlling Symptoms & Reducing Your Child's Dependence on Drugs by M.D., Steven J. Bock, M.D., Kenneth Bock A groundbreaking, practical, and holistic approach to treating children with chronic asthma From two physicians with fifteen years of experience in treating asthma comes the only book for children with asthma that supplements conventional approaches with effective and proven natural remedies. Parenting a child with asthma is often scary, unpredictable, frustrating, and expensive. Through... |
 | The Lion Who Had Asthma by Jonathan London Sean's nebulizer mask and his imagination aid in his recovery following an asthma attack. Includes information on childhood asthma and how to control its... |
 | The Harvard Medical School Guide To Taking Control Of Asthma by Christopher H. Fanta, Lynda M. Cristiano, Kenan Haver Take control of your asthma now wih this easy-to-follow personalized approachShortness of breath. Tightness in the chest. Wheezing and coughing. These distressing symptoms are a daily fact of life for many of the fifteen million Americans who suffer from asthma, including nearly six million children -- and asthma is on the rise. But even those with severe asthma can lead full, active lives with... |
 | The Asthma Educators Handbook by Christopher H. Fanta, Elaine L. Carter, Elisabeth S. Stieb, Kenan E. Haver Learn asthma care essentials--from top experts at the Partners Asthma Center Internists, family physicians, physician's assistants, respiratory therapists, and pharmacists will find this unparalleled, authoritative guide has everything needed to understand and treat asthma in children and adults. Ideal for preparing for certification as an asthma educator (AE-C), The Asthma Educator's... |
 | The Children's Hospital of Philadelphia Guide to Asthma: How to Help Your Child Live a Healthier Life by Children's Hospital of Philadelphia While asthma can't be cured, it can be treated and controlled so that your child can enjoy a healthier, more active life. In this important guide, the experts at the top-ranked children's hospital in the United States clearly explain what asthma is and how parents, caregivers, and young patients can manage it successfully. The Children's Hospital of Philadelphia Guide to Asthma features the most... |
| © 2008 BrightSurf.com |